Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water

NCT ID: NCT04567108

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

460 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-22

Study Completion Date

2026-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sugar-sweetened beverages (SSBs) contribute an alarming \~7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Therefore, the investigators will conduct a 4-arm randomized diet intervention trial to test the effects of substituting SSBs with calorie-free alternatives on body weight and health, among habitual SSB consumers with overweight/obesity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The SUBstituting with Preferred OPtions (SUB-POP) trial, is a parallel-arm randomized controlled trial (RCT) to test the effects of substituting SSBs with non-caloric options on body weight and markers of type 2 diabetes and cardiometabolic health. Eligible adult participants will be randomized to 1 of 4 beverage groups and receive at-home monthly deliveries of beverages for 6 months. In-person clinic visits will be conducted at baseline, 6, and 12 months. After the 6 months of assigned beverage substitution and delivery, all participants will be instructed to substitute SSBs with water only for a final 6-month observational period. In-person clinic visits will collect technician-measured anthropometrics, blood pressure, biospecimen samples (blood, urine, stool \[subset\]), and assess physical activity, diet, beverage frequency, and taste preference. The SUB-POP app-based assessments and online diet recall will ascertain daily beverage intake, while diet (via 3 24-hour recalls), physical activity, and overall beverage frequency will be collected every 1-3 months. A subset will receive at-home digital scales to transmit daily body weight for energy balance and caloric compensation modeling. SUB-POP is a novel RCT that will enroll adult regular SSB consumers with overweight or obesity to evaluate the effectiveness of substituting SSBs with non-caloric options in a real-world, un-blinded setting. The trial will leverage social media recruitment methods, achieve ≥30% non-White participants, implement innovative intervention delivery, adherence, and data collection tools, and partition the artificially-sweetened beverage (ASB) substitution intervention to the two most common artificial sweetener types (aspartame, sucralose) to explore potential heterogeneity. Whether ASBs, which are largely free of calories and sugar, provide a healthful interim strategy to transition to water among habitual SSB consumers is unknown. Thus, by addressing this large gap in the understanding of how to address a highly prevalent and concerning dietary exposure, the investigators will inform dietary guidelines and clinical recommendations for the prevention of obesity, type 2 diabetes, and cardiometabolic disease risks. The primary outcomes are change in body weight from baseline to 6 months between the 3 beverage substitution groups (aspartame ASBs, sucralose ASBs, and water) vs. the maintain SSBs control group, adjusting for multiple comparisons. The investigators and staff will be blinded to group assignment at outcome assessments. Intention-to-treat analysis will be used.

After 9/1/2023 the 2 ASB intervention groups (sucralose, aspartame) are combined into a single ASB intervention group; participants randomized on or after 9/1/2023 will be randomized to 1 of 3 beverage groups: maintain SSBs (months 0-6; then switch to water months 6-12); switch to ASBs (months 0-6; then switch to water months 6-12); switch to water (months 0-12). The primary outcomes are change in body weight from baseline to 6 months between the 2 beverage substitution groups (ASBs \[all ASB intervention groups combined\] and water) vs. the maintain SSBs control group, adjusting for multiple comparisons.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Body Weight

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel randomization on a rolling basis to one of 4 interventions; After 9/1/2023 design is modified to 3 parallel interventions, with sucralose and aspartame interventions combined into one ASB substitution arm
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
Outcomes assessor will be blinded to participants' beverage assignment at time of outcome assessment; Investigators will be masked to treatment arm assignments during primary analyses

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Maintain SSBs (Control)

Instruction to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)

Group Type ACTIVE_COMPARATOR

Maintain usual SSBs

Intervention Type BEHAVIORAL

Instruction/guidelines to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)

Study app

Intervention Type BEHAVIORAL

Engage with a motivational mobile app to track beverage intake and complete study data collection

Beverage delivery

Intervention Type BEHAVIORAL

Select from approved beverages for a monthly at-home delivery (months 0-6)

Substitute Aspartame ASBs (participants randomized through 8/31/2023)

Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with aspartame (months 0-6); then switch to water only (months 6-12)

Group Type EXPERIMENTAL

Substitute to non-SSBs

Intervention Type BEHAVIORAL

Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)

Study app

Intervention Type BEHAVIORAL

Engage with a motivational mobile app to track beverage intake and complete study data collection

Beverage delivery

Intervention Type BEHAVIORAL

Select from approved beverages for a monthly at-home delivery (months 0-6)

Substitute Sucralose ASBs (participants randomized through 8/31/2023)

Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with sucralose (months 0-6); then switch to water only (months 6-12)

Group Type EXPERIMENTAL

Substitute to non-SSBs

Intervention Type BEHAVIORAL

Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)

Study app

Intervention Type BEHAVIORAL

Engage with a motivational mobile app to track beverage intake and complete study data collection

Beverage delivery

Intervention Type BEHAVIORAL

Select from approved beverages for a monthly at-home delivery (months 0-6)

Substitute Water

Instruction/guidelines to eliminate SSBs and replace with water (months 0-12)

Group Type EXPERIMENTAL

Substitute to non-SSBs

Intervention Type BEHAVIORAL

Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)

Study app

Intervention Type BEHAVIORAL

Engage with a motivational mobile app to track beverage intake and complete study data collection

Beverage delivery

Intervention Type BEHAVIORAL

Select from approved beverages for a monthly at-home delivery (months 0-6)

Substitute ASBs (participants randomized on or after 9/1/2023)

Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with choice of non-nutritive sweeteners such as sucralose or aspartame

Group Type EXPERIMENTAL

Substitute to non-SSBs

Intervention Type BEHAVIORAL

Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)

Study app

Intervention Type BEHAVIORAL

Engage with a motivational mobile app to track beverage intake and complete study data collection

Beverage delivery

Intervention Type BEHAVIORAL

Select from approved beverages for a monthly at-home delivery (months 0-6)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maintain usual SSBs

Instruction/guidelines to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)

Intervention Type BEHAVIORAL

Substitute to non-SSBs

Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)

Intervention Type BEHAVIORAL

Study app

Engage with a motivational mobile app to track beverage intake and complete study data collection

Intervention Type BEHAVIORAL

Beverage delivery

Select from approved beverages for a monthly at-home delivery (months 0-6)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults aged 20-69 years
2. Consume ≥1 serving/day (12 oz.) of SSBs (SSBs include soda, fruit drinks, energy drinks, sports drinks, and sweetened waters, sweetened with high fructose corn syrup, sucrose, or fruit juices. SSBs do not include 100% fruit juice, sweetened teas, or flavored milk.)
3. BMI 25.0 to 45.0 kg/m2
4. Access to a smartphone and willingness and ability to download study app
5. Willing to consume beverages consistent with any of the 4 possible group assignments for 6 months

Exclusion Criteria

1. Physician diagnosis of T2D or fasting glucose ≥126 mg/dL at in-person screening visit
2. Intention to move away from greater Boston area within 1 year from randomization
3. Major medical illness (known cardiovascular disease, cancer, kidney disease, cirrhosis, etc.)
4. Phenylketonuria (PKU)
5. Medication that may affect weight or other study endpoints
6. Another family or household member participating in the study
7. Pregnant in the past 12 months, currently breastfeeding, or planning to become pregnant during the study period
Minimum Eligible Age

20 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role collaborator

Brigham and Women's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Deirdre K Tobias, ScD

Assistant Professor, Associate Epidemiologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Deirdre Tobias, ScD

Role: PRINCIPAL_INVESTIGATOR

Brigham and Women's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01DK125803-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2020p002494

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Metabolic Effects of Non-Nutritive Sweeteners
NCT01200940 COMPLETED PHASE1/PHASE2